# Effect of Prolonged Use of Dronedarone on Recurrence in Patients With Non-paroxysmal Atrial Fibrillation After Radiofrequency Ablation

> **NCT05655468** · PHASE4 · UNKNOWN · sponsor: **Shanghai East Hospital** · enrollment: 268 (estimated)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **DRUG:** Dronedarone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05655468
- **Lead sponsor:** Shanghai East Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-03-29
- **Primary completion:** 2025-04
- **Final completion:** 2025-11
- **Target enrollment:** 268 (ESTIMATED)
- **Last updated:** 2023-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05655468

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05655468, "Effect of Prolonged Use of Dronedarone on Recurrence in Patients With Non-paroxysmal Atrial Fibrillation After Radiofrequency Ablation". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05655468. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*